压力计量剂量吸入器执行器孔径对吸入上腺素区域额外胸部沉积的影响
Conor A Ruzycki1,2, Scott Tavernini1, George Luciuk3
1Department of Mechanical Engineering, Faculty of Engineering, University of Alberta, Edmonton, Canada.
Journal of aerosol medicine and pulmonary drug delivery
|April 21, 2025
概括
上腺素吸入器中较小的执行器孔减少了口服沉积,并增加了肺部的输送. 这种优化最大限度地减少了与患者技术相关的剂量变化,改善了压力计量剂量吸入器 (pMDI) 气溶的有效性.
科学领域:
- 制药科学 制药科学
- 气溶科学与技术 气溶科学与技术
- 药物输送系统 药物输送系统
背景情况:
- 压力计量剂量吸入器 (pMDI) 气溶的额外胸部沉积会导致体内显著的剂量变化.
- 以前的研究主要集中在总额外胸部沉积,忽视了区域分析.
- 了解区域胸外沉积对于优化pMDI性能至关重要.
研究的目的:
- 评估执行器孔径和吸入流量对上腺素pMDI的区域胸外沉积的影响.
- 研究这些因素如何影响特定胸外区域 (口腔,喉/喉,上气管) 的沉积.
主要方法:
- 使用了商业上可用的化 (HFA) 悬浮 pMDI 配方的上腺素.
- 区域沉积被评估使用一个切断的阿尔伯塔理想化喉 (s-AIT) 模型 (塑料和金属版本).
- 该研究检查了不同流速 (10-100L/分钟) 的执行器孔径和吸入器插入角度的变化.
主要成果:
- 较小的执行器孔显著减少了口腔沉积,并增加了距离波器 (模拟肺) 中的沉积.
- 更高的吸入流速导致口腔沉积减少,但喉/喉和上气管中的沉积增加.
- 较小的孔径显示,与吸入器插入角度相关的沉积变化较小.
结论:
- 执行器孔径是影响HFA上腺素pMDI气溶区域外胸部沉积的关键因素.
- 较小的孔通过减少口服沉积来增强肺部的输送,并可能减轻与患者技术相关的剂量变化.
- 优化执行器孔设计有可能提高pMDI治疗的疗效和一致性.
相关概念视频
Inhaled Medications
197
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
197
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Adrenergic Agonists: Mixed-Action Agents
617
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
617
Antiasthma Drugs: β2-Adrenoceptor Agonists
147
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
147
Pressure Relationships in Thoracic Cavity
1.6K
Breathing, otherwise known as pulmonary ventilation, is the process of air movement into and out of the lungs. The main mechanisms propelling pulmonary ventilation are atmospheric pressure (Patm), intra-pulmonary (Ppul ) or intra-alveolar pressure (Palv) within the alveoli, and intrapleural pressure (Pip) within the pleural cavity.
Breathing Mechanisms
Both intra-alveolar and intrapleural pressures rely on specific lung properties. The ability to breathe—allowing air to enter the lungs...
Breathing Mechanisms
Both intra-alveolar and intrapleural pressures rely on specific lung properties. The ability to breathe—allowing air to enter the lungs...
1.6K
Factors Affecting Pulmonary Ventilation
967
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
967


